Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 November, 2018 19:10 IST
Lupin launches generic Kapvay tablets in US
Source: IRIS | 08 Feb, 2018, 04.03PM
Comments  |  Post Comment

Pharma major Lupin announced the launch of its Clonidine Hydrochloride extended-release tablets, 0.1mg, having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin's Clonidine Hydrochloride ER tablets is the generic equivalent of Concordia International Corp's Kapvay tablets. It is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) as monotherapy or as adjunctive therapy to stimulant medications.

Kapvay tablets had annual sales of approximately USD 66 million in the US (IQVIA MAT December 2017). 

Shares of the company gained Rs 6.5, or 0.8%, to settle at Rs 814.45. The total volume of shares traded was 154,072 at the BSE (Thursday).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Dr. Reddy's Laboratories gets favourable decision in patent litigation in US court - 21-Nov-2018 09:38
Rajesh Exports bags export order worth Rs 9.33 bn - 21-Nov-2018 09:27
Gayatri Projects declared as lowest bidder for project worth Rs 1.62 bn - 20-Nov-2018 14:55
Ramco Systems wins contract from leading casino and resorts provider - 20-Nov-2018 14:52
Zydus Cadila receives tentative approval for Deferasirox tablets - 20-Nov-2018 14:49
Kridhan Infra arm wins orders worth Rs 1.95 bn - 20-Nov-2018 09:35
Glenmark Pharma receives approval for Azelaic acid gel - 20-Nov-2018 09:31
PSP Projects' total work order stands at Rs 8.04 bn in FY19 - 20-Nov-2018 09:28
TCS partners with SAP to build intelligent rail digital maintenance solution - 20-Nov-2018 09:27
Zydus receives final approval from USFDA for Abacavir & Lamivudine Tablets and Fondaparinux Sodium Injection - 19-Nov-2018 09:51
Infosys starts construction of U.S education center in Indianapolis - 19-Nov-2018 09:41
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer